WHY YOU SHOULD WATCH THIS FREE WEBINAR:
An increasing number of institutions are using heated high flow nasal cannula as a primary form of noninvasive respiratory support for infants. This presentation will explore the available data to improve our understanding of how HFNC works and how it can safely and effectively be used to reduce WOB improve gas exchange and reduce the need for invasive mechanical ventilation.
Describe at least two theoretic and/or physiologic differences between the function of Nasal CPAP and high flow nasal cannula (HFNC)
Discuss the type and quality of clinical data that currently exists for using HFNC in neonates
List two or more best practices for HFNC management and weaning
Rob DiBlasi RRT-NPS, FAARC
Rob DiBlasi is Manager of Research in the Respiratory Care Department at the Seattle Children’s. Rob manages clinical, aerosol and animal research as Program Manager for Translational Respiratory Research at the Seattle Children’s Hospital Research Institute. His research interests include: neonatal pulmonary mechanics monitoring, patient/ventilator interaction, ventilator induced lung injury, neonatal lung protective strategies, mechanical ventilator performance, and aerosolization of respiratory medications. He is also a fellow of the American Association for Respiratory Care
Share this page with your friends...